Square Pharma to start drug production in Kenya by January
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
The Business Standard

Monday
February 06, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
MONDAY, FEBRUARY 06, 2023
Square Pharma to start drug production in Kenya by January

Stocks

TBS Report
29 November, 2021, 10:30 pm
Last modified: 30 November, 2021, 01:07 pm

Related News

  • CAB demands halt to medicine price hike
  • UN asks Kenya to hold thorough inquiry into Pakistani journalist Arshad Sharif's death
  • Pakistani journalist Arshad Sharif killed in police shooting in Kenya
  • Pakistani journalist Arshad Sharif killed in police shooting in Kenya
  • New drugs, strong marketing help Square Pharma maintain growth trend

Square Pharma to start drug production in Kenya by January

The company constructed a Tk170 crore manufacturing plant in Nairobi

TBS Report
29 November, 2021, 10:30 pm
Last modified: 30 November, 2021, 01:07 pm
Square Pharma to start drug production in Kenya by January

Square Pharmaceuticals Ltd is going to be the first Bangladeshi company to produce medicines in a foreign country as it is scheduled to start manufacturing in Kenya by January 2022.

The trial operation will start in December this year.

As per the company's financial statement, the construction of the project began in 2019 and was initially scheduled to be completed by early 2021.

However, the global outbreak of Covid-19 impacted the construction work to a great extent.

Finally, Square completed the construction of its manufacturing plant in Nairobi, the Kenyan capital in September 2021 at a cost of Tk170 crore.

The pharma giant looks to get hold of the $30 million drug market in Kenya and five other East African countries – Tanzania, Rwanda, Burundi, Uganda, and South Sudan – and fulfil the unmet demands of medicines in those countries.

According to the company's 2017 disclosure on the Dhaka Stock Exchange, Square invested $20 million to set up a drug manufacturing plant in Kenya.

Square Pharma spent $8 million from its fund and the rest of the amount was arranged through a loan.

Square currently exports medicine to 42 countries, including 19 in Asia, 13 in Africa, three in Oceania, six in Central and South Americas, and the United Kingdom.

From July to September of the current fiscal year, the gross revenue of the company was Tk1,742 crore, which was Tk1,472 crore in the same period of the previous FY.

During the period, its total comprehensive income was Tk595 crore and earnings per share were Tk5.64.

As of 31 October 2021, the sponsors and directors jointly held 34.57% shares, institutions 14.03% shares, foreign investors 14.26% shares and the general public 37.14% shares in the company.

The last traded share price of the company at the Dhaka Stock Exchange was Tk217.20 on Monday.

Top News

Square Pharmaceuticals Ltd / Kenya / Drug production

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • GDP growth drops to 7.1% in FY22, per capita income $2,793
    GDP growth drops to 7.1% in FY22, per capita income $2,793
  • Consumers should pay actual costs to get gas, electricity: PM
    Consumers should pay actual costs to get gas, electricity: PM
  • Dr Debapriya Bhattacharya. Illustration: TBS
    Development won't sustain sans political consensus: Debapriya 

MOST VIEWED

  • Global fashion retailer C&A warns C&A Textiles of legal action for using same name
    Global fashion retailer C&A warns C&A Textiles of legal action for using same name
  • Photo: Mumit M
    'Ineligible', still recommended for DSE MD post
  • BSEC approves Alif Manufacturing’s revised fund utilisation plan
    BSEC approves Alif Manufacturing’s revised fund utilisation plan
  • Stocks slip amid profit booking, portfolio rebalancing
    Stocks slip amid profit booking, portfolio rebalancing
  • Adani vs Hindenburg: What's short selling? Are bears the monsters?
    Adani vs Hindenburg: What's short selling? Are bears the monsters?
  • BSEC recasts board to make Imam Button functional
    BSEC recasts board to make Imam Button functional

Related News

  • CAB demands halt to medicine price hike
  • UN asks Kenya to hold thorough inquiry into Pakistani journalist Arshad Sharif's death
  • Pakistani journalist Arshad Sharif killed in police shooting in Kenya
  • Pakistani journalist Arshad Sharif killed in police shooting in Kenya
  • New drugs, strong marketing help Square Pharma maintain growth trend

Features

Say it with Colours

Say it with Colours

21h | Mode
Photo: Courtesy

From 'Made in Bangladesh' to 'Designed in Bangladesh'

23h | Panorama
Google must adjust to a world where content is increasingly generated by AI. Photo: Bloomberg

Google will join the AI wars, pitting LaMDA against ChatGPT

20h | Panorama
The megaproject Rooppur Nuclear Power Plant has a debt of Tk90,474 crore. Photo: Courtesy

Projects funded with debt need to be selected prudently, and implemented timely

21h | Panorama

More Videos from TBS

ICB to withdraw Padma Bank Investment as return

ICB to withdraw Padma Bank Investment as return

13h | TBS Insight
Kiara Advani & Sidharth Malhotra's Wedding Update

Kiara Advani & Sidharth Malhotra's Wedding Update

13h | TBS Entertainment
What you probably didn't know about CR7

What you probably didn't know about CR7

11h | TBS SPORTS
US shoots down Chinese spy balloon

US shoots down Chinese spy balloon

12h | TBS World

Most Read

1
Leepu realised his love for cars from a young age and for the last 40 years, he has transformed, designed and customised hundreds of cars. Photo: Collected
Panorama

'I am not crazy about cars anymore': Nizamuddin Awlia Leepu

2
The International Monetary Fund (IMF) logo is seen outside the headquarters building in Washington, U.S., September 4, 2018. REUTERS/Yuri Gripas/File Photo
Economy

IMF approves $4.7 billion loan for Bangladesh, calls for ambitious reforms

3
Fund cut as Dhaka's fast-track transit projects on slow spending lane
Infrastructure

Fund cut as Dhaka's fast-track transit projects on slow spending lane

4
Photo: Collected
Court

Japanese mother gets guardianship of daughters, free to leave country

5
Belal Ahmed new acting chairman of SIBL
Banking

Belal Ahmed new acting chairman of SIBL

6
Photo: Collected
Startups

ShopUp secures $30m debt financing to boost expansion, supply chain

EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]